oral semaglutide weight loss fda Novo Nordisk's Wegovy® pill (oral 25 mg, once daily) has just been approved by the US as the first GLP‑1 receptor agonist for long‑term management and CV risk Novo Nordisk's weight-loss pill wins

A clinical trial published in the Journal of Dermatological Science found that consistent use of glutathione helped in reducing UV-induced pigmentation and oxidative stress, leading to visibly healthier skin

What are the main safety concerns with combining these medications

Corticosteroids can blunt GH release and interact with the axis

This hypothesis deserves further study

The microbiome, cancer, and cancer therapy

Prof Kamila Hawthorne, chairman of the Royal College of GPs, said: "This research makes for interesting reading, and, as more research is conducted and published, it's important that findings are considered as clinical guidelines for use of liraglutide, semaglutide and other weight loss medications are updated and developed